finasteride zona frontale

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, clomid vs hcg 2021. REUTERS/Adnan Abidi//File Photo

NEW DELHI (Reuters) – India said on Friday monthly production capacity of its homegrown COVID-19 shot will be raised to nearly 100 million doses by September, as it tries to overcome a shortage amid a record surge in cases.

“The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021,” the Ministry of Science & Technology said in a statement, pegging current capacity at 10 million doses.

Source: Read Full Article